BioSpace News Archive

CyberMDX, a leading healthcare cybersecurity provider delivering visibility, threat prevention, and operational efficiency for medical devices, IoT, and clinical networks, announced today it secured $20 million in funding, bringing its fundraising total to $30 million.

The COVID-19 Pandemic has drastically changed which products and services are being bought and how they are being purchased.

Qosina carries a broad selection of in-stock, single-use bioprocessing components. The company provides 3D CAD models and comprehensive technical specifications, such as material safety data sheets, technical data sheets, material certification and compatibility information on most of these products. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, reflecting its unwavering commitment to providing high

Veeva to design digital strategies and implementation roadmap to help field teams better connect with HCPs Veeva establishes alliances with Accenture, Deloitte, and other partners to enable industrywide digital transformation initiatives and get customers up and running fast PLEASANTON, Calif.--( BUSINESS WIRE )-- Veeva Systems (NYSE:VEEV) today announced industry alliances to accelerate the industrywide shift toward digital engagement. Toge

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced financial results for the third quarter of fiscal year 2020, which ended February 29, 2020.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in the Needham & Company 19 th Annual Healthcare Conference. The conference, which will take place Apr

Swedish Orphan Biovitrum AB has released the company’s 2019 Annual and Sustainability Report.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside discussion at the Needham Virtual

Infinity Pharmaceuticals, Inc. provided an update in response to the COVID-19 pandemic.

Marketplace for scientific services named one of the 500 fastest-growing companies in North and South America